2 domains / 4 areas / 3 specializations
CTC Clinical Trial Consultants AB
Data updated
Full-service CRO with in-house research units in Sweden and the Netherlands. Psychedelic-specific evidence remains weaker than its general CNS and early-phase site-network capability.
Clinical Trial Infrastructure Snapshot
CROs & Full-Service Trial DeliveryService Model
Full-Service CRO
Service Coverage
2 countries
Psychedelic Experience
Claimed Psychedelic Trial Experience
Last Source Check
Jun 18, 2026
Public Sources
3
Lifecycle Coverage
Service Coverage Countries
Phase Coverage
Capabilities
Research Update
Public-source profile available
Last checked Jun 18, 2026 across 3 sources.
Search Finding
Strong CRO/site-network evidence; psychedelic-specific signal remains weaker and needs stronger primary confirmation.
Source Caution
General CRO/site-network capability is clear, but the psychedelic-specific role needs stronger primary-source confirmation.
Service Notes
Keep CTC in CTI because the CRO and in-house site network fit the bucket, but treat psychedelic relevance as needs-review until sponsor or registry evidence is stronger.
Linked Stakeholders
No linked stakeholders yet.
Consultancy & Advisory Snapshot
Clinical & Operational ConsultingGeography
Regional
Coverage
2 countries
Psychedelic Focus
Psychedelic-Adjacent Focus
Engagement
Active
Pipeline Stage Coverage
Client Types
Consultancy Notes
CTC Clinical Trial Consultants AB is a full-service CRO headquartered in Uppsala, Sweden, running Phase 0 to Phase II trials and medical device investigations through six Swedish research clinics and one in Groningen, the Netherlands. Its documented psychedelic work is participation in PsyPal, the EU Horizon-funded multi-site trial of psilocybin therapy for psychological distress in palliative care.
Documented Engagements
PsyPal psilocybin palliative care trial (Horizon Europe)
Jan 1, 2024
PsyPal consortium (coordinated by University Medical Centre Groningen)
CTC is a listed SME participant in the 19-partner EU-funded PsyPal trial (2024 to 2027) with an EU contribution of EUR 328,089.
Psilocybin Therapy for Psychological Distress in Palliative Care Patients | PsyPal | CORDISSource Evidence
CTC Clinical Trial Consultants AB (official website)
https://www.ctc-ab.se/
PsyPal project fact sheet, CORDIS, European Commission
https://cordis.europa.eu/project/id/101137378
European Union funds groundbreaking research into psychedelic therapy (UMCG)
https://umcgresearch.org/w/european-union-funds-groundbreaking-research-into-psychedelic-therapy
Quick Facts
- Type
- Other
- HQ
- Uppsala office - Dag Hammarskjolds vag 10B, 752 37 Uppsala, Sweden
- Website
- Visit